Our previous research indicated that reduced FKBP5 levels in endometrial adenocarcinoma tissues promote cancer cell proliferation by increasing p-AKT levels while simultaneously decreasing the sensitivity of these cancer cells to progesterone therapy. This evidence concerns the gene FKBP5 and cancer.